About
29.68USD-0.86 -2.82%
Closed • Updated at 00:25 GMT+00:00Market Cap$1.94B
Volume291.1K
Beta0.61
RSI50.52
Pharvaris N.v. — investor relations, events, news, and company updates on 6ix.
Latest News
May 11 2026
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 8 2026
Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares
Apr 20 2026
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
Apr 2 2026
Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 11 2026
Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology
Community Chat
Ask AI
Try asking
Translate